Hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions, has recently garnered widespread attention as a potential treatment for COVID-19 infection. The authors appraise the study generating this interest and highlight the potential consequences of rapid dissemination of overinterpreted data, particularly for people with conditions for which hydroxychloroquine has demonstrated benefits in preventing organ damage and life-threatening disease flares.
Keywords: Antimalarials; Biomarkers; COVID-19; Chloroquine; Intensive care units; Metastasis; Polymerase chain reaction; Post-exposure prophylaxis; Safety; Viral load.